Using "MOUNJARO" (Tirzepatide) Injection for Diabetes: A Comprehensive Guide To Using Mounjaro Tirzepatide Injection For Treating Type 2 Diabetes [Large Print]

By Dr. Kemp Burton

Type 2 diabetes is a chronic metabolic disorder characterized by high levels of blood sugar (glucose) resulting from insulin resistance and inadequate insulin secretion. Insulin is a hormone produced by the pancreas that helps regulate blood sugar by facilitating the uptake of glucose into cells for energy.

Tirzepatide, approved by the FDA in May 2022, is a medication for managing type 2 diabetes mellitus. It operates as a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist.
Mounjaro is a prescription injectable medication prescribed in conjunction with diet and exercise to enhance blood sugar (glucose) control in adults diagnosed with type 2 diabetes mellitus.

Click buy to get this Product

• Format: Paperback
• Large Print: Yes
• Language: English
• ISBN: B0CRF13QW1
• ISBN13: 9798873417339
• Release Date: December 2023
• Publisher: Independently Published
• Length: 38 Pages
• Weight: 0.14 lbs.
• Dimensions: 0.1" x 6.0" x 9.0"